Synergistic Effect of Vedolizumab and Pentoxifylline

NCT02953275 EARLY_PHASE1 COMPLETED

The purpose of this study is to determine the synergistic effect and clinical benefits of vedolizumab and pentoxifylline in the management of patients with inflammatory bowel disease.

Details

Lead sponsor	University of Miami
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	37
Start date	Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jun 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Crohn Disease

Interventions

• vedolizumab
• Pentoxifylline
• placebo

Countries

United States